NCT05583877

Brief Summary

The specific aims of this project are to culturally adapt the DM-BOOST intervention for Latinx patients, usability test 'DM-BOOST para Latinx' to optimize cultural appropriateness and patient engagement and conduct a feasibility evaluation of DM-BOOST para Latinx. These aims will be accomplished via a community-based participatory research approach in collaboration with clinical, community and patient partners. This project will inform subsequent proposals to evaluate implementation of DM-BOOST in the UMass Memorial Health Care system.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 13, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 18, 2022

Completed
2.3 years until next milestone

Study Start

First participant enrolled

January 29, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2025

Completed
Last Updated

March 3, 2026

Status Verified

February 1, 2026

Enrollment Period

9 months

First QC Date

October 13, 2022

Last Update Submit

February 27, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Process Evaluation

    Evaluate engagement by examining the number of DSMT appointments scheduled, cancellation/no show rates and total number of DSMT-related encounters completed.

    3 - 6 months

Secondary Outcomes (3)

  • Diabetes self-efficacy

    3 months

  • Diabetes treatment satisfaction

    3 months

  • Change in HbA1c Percentage

    6 months

Study Arms (2)

Intervention - Diabetes BOOST

EXPERIMENTAL

Intervention group participants will complete a baseline survey, receive a referral to DSMT from the research team, a mailed welcome letter and self-care education sent via a series of personalized patient portal secure messages, text messages, and video call. They will be sent text messages with information about one of the American Association of Diabetes Educators 7 self-care behaviors and will receive encouragement to author their own self-management behavioral goals. Participants will also complete a telehealth training video call with research staff to review the functionality of their patient portal and refine diabetes-related goals. The participant will then be encouraged to send a patient portal message to their DSMT CDCES that includes their personalized goals prior to their scheduled DSMT session. They will then complete a 3-month follow-up survey and qualitative interview.

Behavioral: Diabetes BOOST

Usual Care

ACTIVE COMPARATOR

Comparison Group participants will complete a baseline survey, receive a DSMT referral request from research team to their primary care provider and a mailed welcome letter. The mailed letter will welcome the participant to the study and contain general information about diabetes self-care behaviors and goal setting. They will complete a DSMT session. They will then complete a 3-month follow-up survey and qualitative interview.

Behavioral: Usual Care

Interventions

Usual CareBEHAVIORAL

Participants will receive usual care for DSMT.

Usual Care
Diabetes BOOSTBEHAVIORAL

Participants will receive supportive care using technology for DSMT in addition to usual care.

Intervention - Diabetes BOOST

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years
  • Diagnosis of type 2 diabetes
  • Identifies as Hispanic/Latinx
  • Spanish language preference

You may not qualify if:

  • Cognitive impairment
  • Current prisoner
  • Pregnant women
  • Age \> 18 years
  • Diagnosis of type 2 diabetes
  • Identifies as Hispanic/Latinx
  • Spanish language preference
  • Cognitive impairment
  • Current prisoner
  • Pregnant women
  • Completed DSMT in previous year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

UMass Memorial health

Worcester, Massachusetts, 01605, United States

Location

University of Massachusetts Medical School

Worcester, Massachusetts, 01655, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Daniel J Amante, PhD, MPH

    UMass Chan Medical School

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
After completing the informed consent, study staff will enter the participant's information into pre-populated REDCap identification numbers. This will assign allocation based on the randomization table. Using this technique, participants will be blinded to allocation. However, research staff will not be blinded to provide personalized training for intervention and control. The investigator will be blinded to randomization for all participants during the study.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The purpose of this study is to culturally-adapt a patient-centric intervention designed to improve implementation of diabetes self-management training in Spanish-speaking patients. To accomplish cultural adaptation of the DM-BOOST intervention, a Patient Research Expert Panel (PREP) (n\</=4) will participate in Community Engagement Studios to inform adaptations (Aim 1) and usability test the intervention (Aim 2). A randomized pilot with new patients (n\</=70) will then be conducted to assess feasibility (Aim 3).
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 13, 2022

First Posted

October 18, 2022

Study Start

January 29, 2025

Primary Completion

October 31, 2025

Study Completion

October 31, 2025

Last Updated

March 3, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations